1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Genital Herpes Treatment Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Acyclovir 1.2.3 Famciclovir 1.2.4 Valacyclovir 1.3 Market by Application 1.3.1 Global Genital Herpes Treatment Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Clinic 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Genital Herpes Treatment Drugs Market Perspective (2017-2028) 2.2 Genital Herpes Treatment Drugs Growth Trends by Region 2.2.1 Genital Herpes Treatment Drugs Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Genital Herpes Treatment Drugs Historic Market Size by Region (2017-2022) 2.2.3 Genital Herpes Treatment Drugs Forecasted Market Size by Region (2023-2028) 2.3 Genital Herpes Treatment Drugs Market Dynamics 2.3.1 Genital Herpes Treatment Drugs Industry Trends 2.3.2 Genital Herpes Treatment Drugs Market Drivers 2.3.3 Genital Herpes Treatment Drugs Market Challenges 2.3.4 Genital Herpes Treatment Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Genital Herpes Treatment Drugs Players by Revenue 3.1.1 Global Top Genital Herpes Treatment Drugs Players by Revenue (2017-2022) 3.1.2 Global Genital Herpes Treatment Drugs Revenue Market Share by Players (2017-2022) 3.2 Global Genital Herpes Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Genital Herpes Treatment Drugs Revenue 3.4 Global Genital Herpes Treatment Drugs Market Concentration Ratio 3.4.1 Global Genital Herpes Treatment Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Genital Herpes Treatment Drugs Revenue in 2021 3.5 Genital Herpes Treatment Drugs Key Players Head office and Area Served 3.6 Key Players Genital Herpes Treatment Drugs Product Solution and Service 3.7 Date of Enter into Genital Herpes Treatment Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Genital Herpes Treatment Drugs Breakdown Data by Type 4.1 Global Genital Herpes Treatment Drugs Historic Market Size by Type (2017-2022) 4.2 Global Genital Herpes Treatment Drugs Forecasted Market Size by Type (2023-2028) 5 Genital Herpes Treatment Drugs Breakdown Data by Application 5.1 Global Genital Herpes Treatment Drugs Historic Market Size by Application (2017-2022) 5.2 Global Genital Herpes Treatment Drugs Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Genital Herpes Treatment Drugs Market Size (2017-2028) 6.2 North America Genital Herpes Treatment Drugs Market Size by Type 6.2.1 North America Genital Herpes Treatment Drugs Market Size by Type (2017-2022) 6.2.2 North America Genital Herpes Treatment Drugs Market Size by Type (2023-2028) 6.2.3 North America Genital Herpes Treatment Drugs Market Share by Type (2017-2028) 6.3 North America Genital Herpes Treatment Drugs Market Size by Application 6.3.1 North America Genital Herpes Treatment Drugs Market Size by Application (2017-2022) 6.3.2 North America Genital Herpes Treatment Drugs Market Size by Application (2023-2028) 6.3.3 North America Genital Herpes Treatment Drugs Market Share by Application (2017-2028) 6.4 North America Genital Herpes Treatment Drugs Market Size by Country 6.4.1 North America Genital Herpes Treatment Drugs Market Size by Country (2017-2022) 6.4.2 North America Genital Herpes Treatment Drugs Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Genital Herpes Treatment Drugs Market Size (2017-2028) 7.2 Europe Genital Herpes Treatment Drugs Market Size by Type 7.2.1 Europe Genital Herpes Treatment Drugs Market Size by Type (2017-2022) 7.2.2 Europe Genital Herpes Treatment Drugs Market Size by Type (2023-2028) 7.2.3 Europe Genital Herpes Treatment Drugs Market Share by Type (2017-2028) 7.3 Europe Genital Herpes Treatment Drugs Market Size by Application 7.3.1 Europe Genital Herpes Treatment Drugs Market Size by Application (2017-2022) 7.3.2 Europe Genital Herpes Treatment Drugs Market Size by Application (2023-2028) 7.3.3 Europe Genital Herpes Treatment Drugs Market Share by Application (2017-2028) 7.4 Europe Genital Herpes Treatment Drugs Market Size by Country 7.4.1 Europe Genital Herpes Treatment Drugs Market Size by Country (2017-2022) 7.4.2 Europe Genital Herpes Treatment Drugs Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Genital Herpes Treatment Drugs Market Size (2017-2028) 8.2 Asia-Pacific Genital Herpes Treatment Drugs Market Size by Type 8.2.1 Asia-Pacific Genital Herpes Treatment Drugs Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Genital Herpes Treatment Drugs Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Genital Herpes Treatment Drugs Market Share by Type (2017-2028) 8.3 Asia-Pacific Genital Herpes Treatment Drugs Market Size by Application 8.3.1 Asia-Pacific Genital Herpes Treatment Drugs Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Genital Herpes Treatment Drugs Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Genital Herpes Treatment Drugs Market Share by Application (2017-2028) 8.4 Asia-Pacific Genital Herpes Treatment Drugs Market Size by Region 8.4.1 Asia-Pacific Genital Herpes Treatment Drugs Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Genital Herpes Treatment Drugs Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Genital Herpes Treatment Drugs Market Size (2017-2028) 9.2 Latin America Genital Herpes Treatment Drugs Market Size by Type 9.2.1 Latin America Genital Herpes Treatment Drugs Market Size by Type (2017-2022) 9.2.2 Latin America Genital Herpes Treatment Drugs Market Size by Type (2023-2028) 9.2.3 Latin America Genital Herpes Treatment Drugs Market Share by Type (2017-2028) 9.3 Latin America Genital Herpes Treatment Drugs Market Size by Application 9.3.1 Latin America Genital Herpes Treatment Drugs Market Size by Application (2017-2022) 9.3.2 Latin America Genital Herpes Treatment Drugs Market Size by Application (2023-2028) 9.3.3 Latin America Genital Herpes Treatment Drugs Market Share by Application (2017-2028) 9.4 Latin America Genital Herpes Treatment Drugs Market Size by Country 9.4.1 Latin America Genital Herpes Treatment Drugs Market Size by Country (2017-2022) 9.4.2 Latin America Genital Herpes Treatment Drugs Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Genital Herpes Treatment Drugs Market Size (2017-2028) 10.2 Middle East & Africa Genital Herpes Treatment Drugs Market Size by Type 10.2.1 Middle East & Africa Genital Herpes Treatment Drugs Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Genital Herpes Treatment Drugs Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Genital Herpes Treatment Drugs Market Share by Type (2017-2028) 10.3 Middle East & Africa Genital Herpes Treatment Drugs Market Size by Application 10.3.1 Middle East & Africa Genital Herpes Treatment Drugs Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Genital Herpes Treatment Drugs Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Genital Herpes Treatment Drugs Market Share by Application (2017-2028) 10.4 Middle East & Africa Genital Herpes Treatment Drugs Market Size by Country 10.4.1 Middle East & Africa Genital Herpes Treatment Drugs Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Genital Herpes Treatment Drugs Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 AstraZeneca, Plc. 11.1.1 AstraZeneca, Plc. Company Details 11.1.2 AstraZeneca, Plc. Business Overview 11.1.3 AstraZeneca, Plc. Genital Herpes Treatment Drugs Introduction 11.1.4 AstraZeneca, Plc. Revenue in Genital Herpes Treatment Drugs Business (2017-2022) 11.1.5 AstraZeneca, Plc. Recent Developments 11.2 Apotheca, Inc. 11.2.1 Apotheca, Inc. Company Details 11.2.2 Apotheca, Inc. Business Overview 11.2.3 Apotheca, Inc. Genital Herpes Treatment Drugs Introduction 11.2.4 Apotheca, Inc. Revenue in Genital Herpes Treatment Drugs Business (2017-2022) 11.2.5 Apotheca, Inc. Recent Developments 11.3 Asahi Kasei Pharma Corporation 11.3.1 Asahi Kasei Pharma Corporation Company Details 11.3.2 Asahi Kasei Pharma Corporation Business Overview 11.3.3 Asahi Kasei Pharma Corporation Genital Herpes Treatment Drugs Introduction 11.3.4 Asahi Kasei Pharma Corporation Revenue in Genital Herpes Treatment Drugs Business (2017-2022) 11.3.5 Asahi Kasei Pharma Corporation Recent Developments 11.4 Carlsbad Technology, Inc. 11.4.1 Carlsbad Technology, Inc. Company Details 11.4.2 Carlsbad Technology, Inc. Business Overview 11.4.3 Carlsbad Technology, Inc. Genital Herpes Treatment Drugs Introduction 11.4.4 Carlsbad Technology, Inc. Revenue in Genital Herpes Treatment Drugs Business (2017-2022) 11.4.5 Carlsbad Technology, Inc. Recent Developments 11.5 GlaxoSmithkline, Plc. 11.5.1 GlaxoSmithkline, Plc. Company Details 11.5.2 GlaxoSmithkline, Plc. Business Overview 11.5.3 GlaxoSmithkline, Plc. Genital Herpes Treatment Drugs Introduction 11.5.4 GlaxoSmithkline, Plc. Revenue in Genital Herpes Treatment Drugs Business (2017-2022) 11.5.5 GlaxoSmithkline, Plc. Recent Developments 11.6 Mylan N.V. 11.6.1 Mylan N.V. Company Details 11.6.2 Mylan N.V. Business Overview 11.6.3 Mylan N.V. Genital Herpes Treatment Drugs Introduction 11.6.4 Mylan N.V. Revenue in Genital Herpes Treatment Drugs Business (2017-2022) 11.6.5 Mylan N.V. Recent Developments 11.7 Novartis AG. 11.7.1 Novartis AG. Company Details 11.7.2 Novartis AG. Business Overview 11.7.3 Novartis AG. Genital Herpes Treatment Drugs Introduction 11.7.4 Novartis AG. Revenue in Genital Herpes Treatment Drugs Business (2017-2022) 11.7.5 Novartis AG. Recent Developments 11.8 Merck & Co., Inc. 11.8.1 Merck & Co., Inc. Company Details 11.8.2 Merck & Co., Inc. Business Overview 11.8.3 Merck & Co., Inc. Genital Herpes Treatment Drugs Introduction 11.8.4 Merck & Co., Inc. Revenue in Genital Herpes Treatment Drugs Business (2017-2022) 11.8.5 Merck & Co., Inc. Recent Developments 11.9 Teva Pharmaceutical Industries Ltd. 11.9.1 Teva Pharmaceutical Industries Ltd. Company Details 11.9.2 Teva Pharmaceutical Industries Ltd. Business Overview 11.9.3 Teva Pharmaceutical Industries Ltd. Genital Herpes Treatment Drugs Introduction 11.9.4 Teva Pharmaceutical Industries Ltd. Revenue in Genital Herpes Treatment Drugs Business (2017-2022) 11.9.5 Teva Pharmaceutical Industries Ltd. Recent Developments 11.10 Zydus Pharmaceuticals, Inc. 11.10.1 Zydus Pharmaceuticals, Inc. Company Details 11.10.2 Zydus Pharmaceuticals, Inc. Business Overview 11.10.3 Zydus Pharmaceuticals, Inc. Genital Herpes Treatment Drugs Introduction 11.10.4 Zydus Pharmaceuticals, Inc. Revenue in Genital Herpes Treatment Drugs Business (2017-2022) 11.10.5 Zydus Pharmaceuticals, Inc. Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

List of Tables Table 1. Global Genital Herpes Treatment Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Acyclovir Table 3. Key Players of Famciclovir Table 4. Key Players of Valacyclovir Table 5. Global Genital Herpes Treatment Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 6. Global Genital Herpes Treatment Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Genital Herpes Treatment Drugs Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Genital Herpes Treatment Drugs Market Share by Region (2017-2022) Table 9. Global Genital Herpes Treatment Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Genital Herpes Treatment Drugs Market Share by Region (2023-2028) Table 11. Genital Herpes Treatment Drugs Market Trends Table 12. Genital Herpes Treatment Drugs Market Drivers Table 13. Genital Herpes Treatment Drugs Market Challenges Table 14. Genital Herpes Treatment Drugs Market Restraints Table 15. Global Genital Herpes Treatment Drugs Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Genital Herpes Treatment Drugs Revenue Share by Players (2017-2022) Table 17. Global Top Genital Herpes Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genital Herpes Treatment Drugs as of 2021) Table 18. Ranking of Global Top Genital Herpes Treatment Drugs Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Genital Herpes Treatment Drugs Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Genital Herpes Treatment Drugs Product Solution and Service Table 22. Date of Enter into Genital Herpes Treatment Drugs Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Genital Herpes Treatment Drugs Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Genital Herpes Treatment Drugs Revenue Market Share by Type (2017-2022) Table 26. Global Genital Herpes Treatment Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Genital Herpes Treatment Drugs Revenue Market Share by Type (2023-2028) Table 28. Global Genital Herpes Treatment Drugs Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Genital Herpes Treatment Drugs Revenue Share by Application (2017-2022) Table 30. Global Genital Herpes Treatment Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Genital Herpes Treatment Drugs Revenue Share by Application (2023-2028) Table 32. North America Genital Herpes Treatment Drugs Market Size by Type (2017-2022) & (US$ Million) Table 33. North America Genital Herpes Treatment Drugs Market Size by Type (2023-2028) & (US$ Million) Table 34. North America Genital Herpes Treatment Drugs Market Size by Application (2017-2022) & (US$ Million) Table 35. North America Genital Herpes Treatment Drugs Market Size by Application (2023-2028) & (US$ Million) Table 36. North America Genital Herpes Treatment Drugs Market Size by Country (2017-2022) & (US$ Million) Table 37. North America Genital Herpes Treatment Drugs Market Size by Country (2023-2028) & (US$ Million) Table 38. Europe Genital Herpes Treatment Drugs Market Size by Type (2017-2022) & (US$ Million) Table 39. Europe Genital Herpes Treatment Drugs Market Size by Type (2023-2028) & (US$ Million) Table 40. Europe Genital Herpes Treatment Drugs Market Size by Application (2017-2022) & (US$ Million) Table 41. Europe Genital Herpes Treatment Drugs Market Size by Application (2023-2028) & (US$ Million) Table 42. Europe Genital Herpes Treatment Drugs Market Size by Country (2017-2022) & (US$ Million) Table 43. Europe Genital Herpes Treatment Drugs Market Size by Country (2023-2028) & (US$ Million) Table 44. Asia Pacific Genital Herpes Treatment Drugs Market Size by Type (2017-2022) & (US$ Million) Table 45. Asia Pacific Genital Herpes Treatment Drugs Market Size by Type (2023-2028) & (US$ Million) Table 46. Asia Pacific Genital Herpes Treatment Drugs Market Size by Application (2017-2022) & (US$ Million) Table 47. Asia Pacific Genital Herpes Treatment Drugs Market Size by Application (2023-2028) & (US$ Million) Table 48. Asia Pacific Genital Herpes Treatment Drugs Market Size by Region (2017-2022) & (US$ Million) Table 49. Asia Pacific Genital Herpes Treatment Drugs Market Size by Region (2023-2028) & (US$ Million) Table 50. Latin America Genital Herpes Treatment Drugs Market Size by Type (2017-2022) & (US$ Million) Table 51. Latin America Genital Herpes Treatment Drugs Market Size by Type (2023-2028) & (US$ Million) Table 52. Latin America Genital Herpes Treatment Drugs Market Size by Application (2017-2022) & (US$ Million) Table 53. Latin America Genital Herpes Treatment Drugs Market Size by Application (2023-2028) & (US$ Million) Table 54. Latin America Genital Herpes Treatment Drugs Market Size by Country (2017-2022) & (US$ Million) Table 55. Latin America Genital Herpes Treatment Drugs Market Size by Country (2023-2028) & (US$ Million) Table 56. Middle East and Africa Genital Herpes Treatment Drugs Market Size by Type (2017-2022) & (US$ Million) Table 57. Middle East and Africa Genital Herpes Treatment Drugs Market Size by Type (2023-2028) & (US$ Million) Table 58. Middle East and Africa Genital Herpes Treatment Drugs Market Size by Application (2017-2022) & (US$ Million) Table 59. Middle East and Africa Genital Herpes Treatment Drugs Market Size by Application (2023-2028) & (US$ Million) Table 60. Middle East and Africa Genital Herpes Treatment Drugs Market Size by Country (2017-2022) & (US$ Million) Table 61. Middle East and Africa Genital Herpes Treatment Drugs Market Size by Country (2023-2028) & (US$ Million) Table 62. AstraZeneca, Plc. Company Details Table 63. AstraZeneca, Plc. Business Overview Table 64. AstraZeneca, Plc. Genital Herpes Treatment Drugs Product Table 65. AstraZeneca, Plc. Revenue in Genital Herpes Treatment Drugs Business (2017-2022) & (US$ Million) Table 66. AstraZeneca, Plc. Recent Developments Table 67. Apotheca, Inc. Company Details Table 68. Apotheca, Inc. Business Overview Table 69. Apotheca, Inc. Genital Herpes Treatment Drugs Product Table 70. Apotheca, Inc. Revenue in Genital Herpes Treatment Drugs Business (2017-2022) & (US$ Million) Table 71. Apotheca, Inc. Recent Developments Table 72. Asahi Kasei Pharma Corporation Company Details Table 73. Asahi Kasei Pharma Corporation Business Overview Table 74. Asahi Kasei Pharma Corporation Genital Herpes Treatment Drugs Product Table 75. Asahi Kasei Pharma Corporation Revenue in Genital Herpes Treatment Drugs Business (2017-2022) & (US$ Million) Table 76. Asahi Kasei Pharma Corporation Recent Developments Table 77. Carlsbad Technology, Inc. Company Details Table 78. Carlsbad Technology, Inc. Business Overview Table 79. Carlsbad Technology, Inc. Genital Herpes Treatment Drugs Product Table 80. Carlsbad Technology, Inc. Revenue in Genital Herpes Treatment Drugs Business (2017-2022) & (US$ Million) Table 81. Carlsbad Technology, Inc. Recent Developments Table 82. GlaxoSmithkline, Plc. Company Details Table 83. GlaxoSmithkline, Plc. Business Overview Table 84. GlaxoSmithkline, Plc. Genital Herpes Treatment Drugs Product Table 85. GlaxoSmithkline, Plc. Revenue in Genital Herpes Treatment Drugs Business (2017-2022) & (US$ Million) Table 86. GlaxoSmithkline, Plc. Recent Developments Table 87. Mylan N.V. Company Details Table 88. Mylan N.V. Business Overview Table 89. Mylan N.V. Genital Herpes Treatment Drugs Product Table 90. Mylan N.V. Revenue in Genital Herpes Treatment Drugs Business (2017-2022) & (US$ Million) Table 91. Mylan N.V. Recent Developments Table 92. Novartis AG. Company Details Table 93. Novartis AG. Business Overview Table 94. Novartis AG. Genital Herpes Treatment Drugs Product Table 95. Novartis AG. Revenue in Genital Herpes Treatment Drugs Business (2017-2022) & (US$ Million) Table 96. Novartis AG. Recent Developments Table 97. Merck & Co., Inc. Company Details Table 98. Merck & Co., Inc. Business Overview Table 99. Merck & Co., Inc. Genital Herpes Treatment Drugs Product Table 100. Merck & Co., Inc. Revenue in Genital Herpes Treatment Drugs Business (2017-2022) & (US$ Million) Table 101. Merck & Co., Inc. Recent Developments Table 102. Teva Pharmaceutical Industries Ltd. Company Details Table 103. Teva Pharmaceutical Industries Ltd. Business Overview Table 104. Teva Pharmaceutical Industries Ltd. Genital Herpes Treatment Drugs Product Table 105. Teva Pharmaceutical Industries Ltd. Revenue in Genital Herpes Treatment Drugs Business (2017-2022) & (US$ Million) Table 106. Teva Pharmaceutical Industries Ltd. Recent Developments Table 107. Zydus Pharmaceuticals, Inc. Company Details Table 108. Zydus Pharmaceuticals, Inc. Business Overview Table 109. Zydus Pharmaceuticals, Inc. Genital Herpes Treatment Drugs Product Table 110. Zydus Pharmaceuticals, Inc. Revenue in Genital Herpes Treatment Drugs Business (2017-2022) & (US$ Million) Table 111. Zydus Pharmaceuticals, Inc. Recent Developments Table 112. Research Programs/Design for This Report Table 113. Key Data Information from Secondary Sources Table 114. Key Data Information from Primary Sources List of Figures Figure 1. Global Genital Herpes Treatment Drugs Market Share by Type: 2021 VS 2028 Figure 2. Acyclovir Features Figure 3. Famciclovir Features Figure 4. Valacyclovir Features Figure 5. Global Genital Herpes Treatment Drugs Market Share by Application: 2021 VS 2028 Figure 6. Hospitals Case Studies Figure 7. Clinic Case Studies Figure 8. Others Case Studies Figure 9. Genital Herpes Treatment Drugs Report Years Considered Figure 10. Global Genital Herpes Treatment Drugs Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global Genital Herpes Treatment Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Genital Herpes Treatment Drugs Market Share by Region: 2021 VS 2028 Figure 13. Global Genital Herpes Treatment Drugs Market Share by Players in 2021 Figure 14. Global Top Genital Herpes Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genital Herpes Treatment Drugs as of 2021) Figure 15. The Top 10 and 5 Players Market Share by Genital Herpes Treatment Drugs Revenue in 2021 Figure 16. North America Genital Herpes Treatment Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 17. North America Genital Herpes Treatment Drugs Market Size Market Share by Type (2017-2028) Figure 18. North America Genital Herpes Treatment Drugs Market Size Market Share by Application (2017-2028) Figure 19. North America Genital Herpes Treatment Drugs Market Size Share by Country (2017-2028) Figure 20. United States Genital Herpes Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Canada Genital Herpes Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Genital Herpes Treatment Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 23. Europe Genital Herpes Treatment Drugs Market Size Market Share by Type (2017-2028) Figure 24. Europe Genital Herpes Treatment Drugs Market Size Market Share by Application (2017-2028) Figure 25. Europe Genital Herpes Treatment Drugs Market Size Share by Country (2017-2028) Figure 26. Germany Genital Herpes Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. France Genital Herpes Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. U.K. Genital Herpes Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Italy Genital Herpes Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Russia Genital Herpes Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Nordic Countries Genital Herpes Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Asia-Pacific Genital Herpes Treatment Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 33. Asia Pacific Genital Herpes Treatment Drugs Market Size Market Share by Type (2017-2028) Figure 34. Asia Pacific Genital Herpes Treatment Drugs Market Size Market Share by Application (2017-2028) Figure 35. Asia Pacific Genital Herpes Treatment Drugs Market Size Share by Region (2017-2028) Figure 36. China Genital Herpes Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Japan Genital Herpes Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. South Korea Genital Herpes Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Southeast Asia Genital Herpes Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. India Genital Herpes Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Australia Genital Herpes Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 42. Latin America Genital Herpes Treatment Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 43. Latin America Genital Herpes Treatment Drugs Market Size Market Share by Type (2017-2028) Figure 44. Latin America Genital Herpes Treatment Drugs Market Size Market Share by Application (2017-2028) Figure 45. Latin America Genital Herpes Treatment Drugs Market Size Share by Country (2017-2028) Figure 46. Mexico Genital Herpes Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 47. Brazil Genital Herpes Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. Middle East & Africa Genital Herpes Treatment Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 49. Middle East and Africa Genital Herpes Treatment Drugs Market Size Market Share by Type (2017-2028) Figure 50. Middle East and Africa Genital Herpes Treatment Drugs Market Size Market Share by Application (2017-2028) Figure 51. Middle East and Africa Genital Herpes Treatment Drugs Market Size Share by Country (2017-2028) Figure 52. Turkey Genital Herpes Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. Saudi Arabia Genital Herpes Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. UAE Genital Herpes Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. AstraZeneca, Plc. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2017-2022) Figure 56. Apotheca, Inc. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2017-2022) Figure 57. Asahi Kasei Pharma Corporation Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2017-2022) Figure 58. Carlsbad Technology, Inc. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2017-2022) Figure 59. GlaxoSmithkline, Plc. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2017-2022) Figure 60. Mylan N.V. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2017-2022) Figure 61. Novartis AG. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2017-2022) Figure 62. Merck & Co., Inc. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2017-2022) Figure 63. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2017-2022) Figure 64. Zydus Pharmaceuticals, Inc. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2017-2022) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

AstraZeneca, Plc. Apotheca, Inc. Asahi Kasei Pharma Corporation Carlsbad Technology, Inc. GlaxoSmithkline, Plc. Mylan N.V. Novartis AG. Merck & Co., Inc. Teva Pharmaceutical Industries Ltd. Zydus Pharmaceuticals, Inc.